Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation and Depletion: 2016-2023

Historic Depreciation and Depletion for Solid Biosciences (SLDB) over the last 8 years, with Dec 2023 value amounting to $2.6 million.

  • Solid Biosciences' Depreciation and Depletion rose 8.91% to $587,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.6 million, marking a year-over-year increase of 7.18%. This contributed to the annual value of $2.6 million for FY2023, which is 7.18% up from last year.
  • Per Solid Biosciences' latest filing, its Depreciation and Depletion stood at $2.6 million for FY2023, which was up 7.18% from $2.4 million recorded in FY2022.
  • In the past 5 years, Solid Biosciences' Depreciation and Depletion ranged from a high of $3.9 million in FY2020 and a low of $2.4 million during FY2022.
  • For the 3-year period, Solid Biosciences' Depreciation and Depletion averaged around $2.7 million, with its median value being $2.6 million (2023).
  • In the last 5 years, Solid Biosciences' Depreciation and Depletion skyrocketed by 80.33% in 2019 and then decreased by 24.43% in 2021.
  • Solid Biosciences' Depreciation and Depletion (Yearly) stood at $2.8 million in 2019, then spiked by 38.88% to $3.9 million in 2020, then fell by 24.43% to $3.0 million in 2021, then dropped by 18.76% to $2.4 million in 2022, then climbed by 7.18% to $2.6 million in 2023.